| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Bruce D Given last filed a Form 4 in April 2020, as Chief Operating Officer at ARWR. Bruce D Given's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 850,730 shares of ARWR. The ARWR filings lean toward selling, a net 784,279 shares.
Bruce D Given has 20 Form 4 filings on record from March 2015 to April 2020, all as Chief Operating Officer at Arrowhead Pharmaceuticals (ARWR), 2015–2020.
The 62 reported transactions were 34 open-market sales, 18 option exercises, 6 stock awards and 2 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 14 sales worth about $14.2M.
The largest open-market sale was 242,834 shares of ARWR at an average $16.04 on February 12, 2019, about $3.9M.
Shares as reported in the last Form 4 for each company; the most recent is from April 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 5,401 | $40.00 | $216,040.00 | -0.6% | |
| Apr 20, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 23,515 | $40.00 | $940,600.00 | -2.7% | |
| Jan 6, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 35,613 | $60.13 | $2,141,285.21 | -4.0% | |
| Mar 1, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 42,500 | $19.99 | $849,575.00 | -6.2% | |
| Feb 25, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 42,500 | $18.98 | $806,650.00 | -6.2% | |
| Feb 19, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 68,750 | $17.86 | $1,227,987.50 | -9.6% | |
| Feb 12, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 242,834 | $16.04 | $3,894,247.00 | -26.6% | |
| Feb 5, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 22,500 | $14.48 | $325,800.00 | -2.6% | |
| Feb 1, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 28,500 | $13.85 | $394,725.00 | -3.2% | |
| Jan 23, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 169,500 | $13.54 | $2,295,805.00 | -15.9% |